Page last updated: 2024-09-04

omeprazole sulfone and mephenytoin

omeprazole sulfone has been researched along with mephenytoin in 4 studies

Compound Research Comparison

Studies
(omeprazole sulfone)
Trials
(omeprazole sulfone)
Recent Studies (post-2010)
(omeprazole sulfone)
Studies
(mephenytoin)
Trials
(mephenytoin)
Recent Studies (post-2010) (mephenytoin)
5012175803532

Protein Interaction Comparison

ProteinTaxonomyomeprazole sulfone (IC50)mephenytoin (IC50)
Cytochrome P450 2C19Homo sapiens (human)1.185

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, K; Ishizaki, T; Kobayashi, K; Lee, KH; Shin, SG; Sohn, DR1
Brockmöller, J; Esdorn, F; Roots, I; Rost, KL1
He, N; Huang, SL; Shu, Y; Wang, LS; Wang, W; Xiao, WM; Xu, ZH; Zhou, HH1
Chow, AH; Chow, MS; Tomlinson, B; Waye, MM; Yin, OQ1

Trials

1 trial(s) available for omeprazole sulfone and mephenytoin

ArticleYear
Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability.
    Journal of clinical pharmacology, 2004, Volume: 44, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; Cross-Over Studies; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Gene Dosage; Humans; Hydroxylation; Male; Mephenytoin; Mixed Function Oxygenases; Omeprazole; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Reference Values

2004

Other Studies

3 other study(ies) available for omeprazole sulfone and mephenytoin

ArticleYear
Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Humans; Hydroxylation; Korea; Male; Mephenytoin; Omeprazole

1992
Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment.
    Journal of hepatology, 1995, Volume: 23, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Ulcer Agents; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Liver Diseases; Male; Mephenytoin; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Phenotype; Polymorphism, Genetic

1995
5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; China; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ethnicity; Gene Dosage; Genotype; Humans; Hydroxylation; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Omeprazole; Substrate Specificity; Troleandomycin

2000